Successful allogeneic stem cell transplantation for Lennert lymphoma

Ann Hematol. 2013 Jun;92(6):859-60. doi: 10.1007/s00277-012-1642-8. Epub 2012 Dec 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation*
  • Carboplatin / administration & dosage
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Epstein-Barr Virus Infections / diagnosis
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lymphoma, T-Cell, Peripheral / drug therapy
  • Lymphoma, T-Cell, Peripheral / surgery*
  • Lymphoma, T-Cell, Peripheral / virology
  • Melphalan / administration & dosage
  • Methotrexate / therapeutic use
  • Middle Aged
  • Nitrosourea Compounds / administration & dosage
  • Pharyngitis / etiology
  • Pharyngitis / virology
  • Prednisolone / administration & dosage
  • Recurrence
  • Rituximab
  • Salvage Therapy*
  • Tacrolimus / therapeutic use
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Vincristine / administration & dosage
  • Whole-Body Irradiation

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Nitrosourea Compounds
  • Cytarabine
  • Rituximab
  • Vincristine
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Carboplatin
  • Cisplatin
  • Melphalan
  • ranimustine
  • Tacrolimus
  • Methotrexate

Supplementary concepts

  • ESHAP regimen, modified